Actively Recruiting

Age: 18Years +
All Genders
NCT07584577

Evaluation of the Administration of Artificial Nutrition by Feeding Jejunostomy During Neoadjuvant Treatment on Postoperative Morbidity in the Context of Esophageal or Stomach Cancer

Led by University Hospital, Bordeaux · Updated on 2026-05-13

670

Participants Needed

1

Research Sites

4 weeks

Total Duration

On this page

Sponsors

U

University Hospital, Bordeaux

Lead Sponsor

F

French Eso-Gastric Tumors Working Group

Collaborating Sponsor

AI-Summary

What this Trial Is About

Malnutrition is common at the time of diagnosis of esogastric cancers. However, there are no recommendations regarding preoperative nutritional support (type and duration) or on the impact of refeeding on postoperative morbidity and mortality.

CONDITIONS

Official Title

Evaluation of the Administration of Artificial Nutrition by Feeding Jejunostomy During Neoadjuvant Treatment on Postoperative Morbidity in the Context of Esophageal or Stomach Cancer

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patient undergoing surgery for esophageal cancer
  • Malnourished patient at the time of management
  • Receiving neoadjuvant treatment
Not Eligible

You will not qualify if you...

  • Patient not malnourished at the time of management
  • Patient who did not receive neoadjuvant treatment

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Hopîtal du Haut Lévêque

Pessac, France, 33600

Actively Recruiting

Loading map...

Research Team

C

Caroline GRONNIER, PhD, MD

CONTACT

V

Valérie AURILLAC

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here